Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19

2020192 citationsJournal Articlegreen Open Access

Authors

Jeffrey S. Berger · NYU Langone Health

Dennis Kunichoff · Population Council

Samrachana Adhikari · Satakunta University of Applied Sciences

Tania Ahuja · NYU Langone Health

Nancy Amoroso · Pulmonary and Critical Care Associates

Yindalon Aphinyanaphongs · Center for Innovation

Meng Cao

Abstract

Abnormal D-dimer was frequently observed at admission with COVID-19 and was associated with higher incidence of critical illness, thrombotic events, acute kidney injury, and death. The optimal management of patients with elevated D-dimer in COVID-19 requires further study.

Topics & Keywords

COVID-19 Clinical Research Studies Venous Thromboembolism Diagnosis and Management Sepsis Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Arteriosclerosis Thrombosis and Vascular Biology

Volume 40, Issue 10, pp. 2539-2547

DOI: 10.1161/atvbaha.120.314872

Field-Weighted Citation Impact: 4.24